| Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis N Kamanamool, M McEvoy, J Attia, A Ingsathit, P Ngamjanyaporn, ... Medicine 89 (4), 227-235, 2010 | 114 | 2010 |
| Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases P Vananuvat, P Suwannalai, S Sungkanuparph, T Limsuwan, ... Seminars in arthritis and rheumatism 41 (3), 497-502, 2011 | 88 | 2011 |
| Performance of cytokine models in predicting SLE activity N Ruchakorn, P Ngamjanyaporn, T Suangtamai, T Kafaksom, ... Arthritis research & therapy 21, 1-11, 2019 | 66 | 2019 |
| Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations JA Reynolds, EM McCarthy, S Haque, P Ngamjanyaporn, JC Sergeant, ... Arthritis research & therapy 20, 1-10, 2018 | 63 | 2018 |
| Nonscarring alopecia in systemic lupus erythematosus: a cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses K Chanprapaph, S Udompanich, Y Visessiri, P Ngamjanyaporn, ... Journal of the American Academy of Dermatology 81 (6), 1319-1329, 2019 | 53 | 2019 |
| The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus C Thanadetsuntorn, P Ngamjanyaporn, C Setthaudom, K Hodge, ... Scientific Reports 8 (1), 2620, 2018 | 43 | 2018 |
| Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus P Ngamjanyaporn, A Thakkinstian, O Verasertniyom, P Chatchaipun, ... Rheumatology international 31, 1215-1218, 2011 | 37 | 2011 |
| Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey P Ngamjanyaporn, EM McCarthy, JC Sergeant, J Reynolds, S Skeoch, ... Lupus Science & Medicine 4 (1), e000173, 2017 | 36 | 2017 |
| Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-γ autoantibodies W Laisuan, P Pisitkun, P Ngamjanyaporn, T Suangtamai, P Rotjanapan Open Forum Infectious Diseases 7 (2), ofaa035, 2020 | 31 | 2020 |
| Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study N Zhong, J Lin, P Mehta, P Ngamjanyaporn, TC Wu, F Yunus BMC Pulmonary Medicine 13, 1-12, 2013 | 31 | 2013 |
| Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial N Kamanamool, A Ingsathit, S Rattanasiri, P Ngamjanyaporn, ... Lupus 27 (4), 647-656, 2018 | 26 | 2018 |
| Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population P Tangtanatakul, C Thumarat, N Satproedprai, P Kunhapan, ... Arthritis research & therapy 22, 1-13, 2020 | 23 | 2020 |
| The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients K Wangriatisak, C Thanadetsuntorn, T Krittayapoositpot, ... Arthritis research & therapy 23, 1-11, 2021 | 22 | 2021 |
| Trichoscopic signs in dermatomyositis, systemic lupus erythematosus, and systemic sclerosis: a comparative study of 150 patients K Chanprapaph, P Limtong, P Ngamjanyaporn, P Suchonwanit Dermatology 238 (4), 677-687, 2022 | 13 | 2022 |
| Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study S Kittivisuit, B Lerkvaleekul, S Soponkanaporn, P Ngamjanyaporn, ... Pediatric Rheumatology 19 (1), 101, 2021 | 12 | 2021 |
| Clinical manifestations, clinical course, and outcomes of immunoglobulin G4‐related disease K Phaopraphat, P Ngamjanyaporn, P Narongroeknawin, N Kasitanon, ... International Journal of Rheumatic Diseases 23 (11), 1468-1473, 2020 | 12 | 2020 |
| Cutaneous and extracutaneous manifestations of Behcet’s disease linked to its disease activity and prognosis P Limtong, K Chanprapaph, V Vachiramon, P Ngamjanyaporn Clinical, Cosmetic and Investigational Dermatology, 639-647, 2020 | 11 | 2020 |
| Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios P Ngamjanyaporn, S Worawichawong, P Pisitkun, K Khiewngam, ... PLoS One 17 (3), e0263778, 2022 | 10 | 2022 |
| Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis A Phuphuakrat, P Ngamjanyaporn, K Nantiruj, V Luangwedchakarn, ... Journal of Microbiology, Immunology and Infection 49 (1), 150-153, 2016 | 10 | 2016 |
| A prospective study of cytomegalovirus-specific cell-mediated immune monitoring and cytomegalovirus infection in patients with active systemic lupus erythematosus receiving … J Bruminhent, S Autto, P Rotjanapan, P Ngarmjanyaporn, A Bushyakanist, ... Open Forum Infectious Diseases 8 (6), ofab248, 2021 | 9 | 2021 |
